Table_3_Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer.xlsx
Long non-coding RNAs (lncRNAs) participate in the regulation of immune response and carcinogenesis, shaping tumor immune microenvironment, which could be utilized in the construction of prognostic signatures for non-small cell lung cancer (NSCLC) as supplements.
MethodsData of patients with stage I-III NSCLC was downloaded from online databases. The least absolute shrinkage and selection operator was used to construct a lncRNA-based prognostic model. Differences in tumor immune microenvironments and pathways were explored for high-risk and low-risk groups, stratified by the model. We explored the potential association between the model and immunotherapy by the tumor immune dysfunction and exclusion algorithm.
ResultsOur study extracted 15 immune-related lncRNAs to construct a prognostic model. Survival analysis suggested better survival probability in low-risk group in training and validation cohorts. The combination of tumor, node, and metastasis staging systems with immune-related lncRNA signatures presented higher prognostic efficacy than tumor, node, and metastasis staging systems. Single sample gene set enrichment analysis showed higher infiltration abundance in the low-risk group, including B cells (p<0.001), activated CD8+ T cells (p<0.01), CD4+ T cells (p<0.001), activated dendritic cells (p<0.01), and CD56+ Natural killer cells (p<0.01). Low-risk patients had significantly higher immune scores and estimated scores from the ESTIMATE algorithm. The predicted proportion of responders to immunotherapy was higher in the low-risk group. Critical pathways in the model were enriched in immune response and cytoskeleton.
ConclusionsOur immune-related lncRNA model could describe the immune contexture of tumor microenvironments and facilitate clinical therapeutic strategies by improving the prognostic efficacy of traditional tumor staging systems.
History
References
- https://doi.org//10.3322/caac.21654
- https://doi.org//10.1016/j.mayocp.2019.01.013
- https://doi.org//10.1038/nrg.2015.10
- https://doi.org//10.1158/2159-8290.CD-11-0209
- https://doi.org//10.1186/1476-4598-10-38
- https://doi.org//10.1016/j.cell.2019.10.017
- https://doi.org//10.1016/j.jtho.2016.01.015
- https://doi.org//10.1016/j.jtho.2017.01.019
- https://doi.org//10.1038/s41423-020-00565-9
- https://doi.org//10.1158/1078-0432.CCR-14-1905
- https://doi.org//10.1038/s41467-020-14802-2
- https://doi.org//10.1038/s41467-018-07767-w
- https://doi.org//10.3892/or.2019.7196
- https://doi.org//10.1016/j.cels.2015.12.004
- https://doi.org//10.1016/j.biopha.2020.111212
- https://doi.org//10.1186/s13046-020-01806-5
- https://doi.org//10.1080/15384101.2019.1646562
- https://doi.org//10.1016/j.canlet.2019.02.036
- https://doi.org//10.3389/fonc.2020.528520
- https://doi.org//10.3892/ol.2017.7656
- https://doi.org//10.1002/cam4.2624
- https://doi.org//10.26355/eurrev_201908_18720
- https://doi.org//10.1016/j.omtn.2019.10.039
- https://doi.org//10.1002/cam4.3046
- https://doi.org//10.1186/s12885-020-07177-6
- https://doi.org//10.1186/s12935-020-01246-3
- https://doi.org//10.1186/s12943-020-01299-y
- https://doi.org//10.3322/caac.21388
- https://doi.org//10.1038/s41568-020-0285-7
- https://doi.org//10.1016/S0140-6736(18)30789-X
- https://doi.org//10.1093/annonc/mdv560
- https://doi.org//10.1097/JTO.0b013e3182037b76
- https://doi.org//10.1002/jcp.27782
- https://doi.org//10.1038/s41577-018-0044-0
- https://doi.org//10.1038/s41577-019-0257-x
- https://doi.org//10.1016/j.immuni.2019.04.011
- https://doi.org//10.1080/2162402X.2020.1747345
- https://doi.org//10.1038/s41467-020-19781-y
- https://doi.org//10.1093/annonc/mdv231
- https://doi.org//10.1186/s13601-020-00335-w
- https://doi.org//10.1016/j.celrep.2015.02.015
- https://doi.org//10.1158/2326-6066.CIR-16-0392
- https://doi.org//10.1038/s41568-019-0116-x
- https://doi.org//10.1158/1078-0432.CCR-18-1538
- https://doi.org//10.1200/JCO.19.00934
CC BY 4.0